Nicholas Butowski, MD, discusses a phase I study of convection-enhanced delivery of nanoliposomal irinotecan (MM-398) for the treatment of recurrent glioblastoma or recurrent high-grade glioma.
Nicholas Butowski, MD
Articles by Nicholas Butowski, MD
Latest Updated Articles
Convection-Enhanced Delivery of Nanoliposomal Irinotecan for Recurrent Glioblastoma or High-Grade GliomaPublished: November 21st 2014 | Updated: